– Company is Focused on Slowing Brain Tumor Progression, Improving Quality of Life for Patients and Caregivers

– Seasoned Life Science Industry Executives Prattipati Laxminarain and Mara Aspinall Join Board of DirectorsContinue reading→

UAVenture Capital has launched a second venture capital fund designed specifically to help finance the commercialization of emerging and disruptive technologies formulated by UA researchers, faculty and students.Continue reading→

Regenerative Medicine Patch Advances Wound RepairContinue reading→

Cancer remains a leading cause of death globally and is the focus of exhaustive and varied medical research. Many of Arizona State University’s Biodesign Institute researchers are working to establish alternative therapies that sidestep the harmful effects of chemotherapy and radiation while improving the success rate for the more difficult-to-treat cancers.Continue reading→

The University of Arizona Cancer Center collaborated with researchers at the Medical University of South Carolina to uncover better ways to harness the immune system to fight cancer.Continue reading→

bioSyntagma has been awarded “Best Oncology-Focused Precision Medicine Company 2018” by Global Health and Pharma, a UK-based publication that recognizes global companies for improving public health, enhancing patient care, and lowering healthcare costs.  This award follows several commercial milestones with strategic partners and Big Pharma using bioSyntagma’s beta-instruments to offer biomarker discovery services.Continue reading→

The IRS information in this post  is provided as a service to AZBio Members and their families.  Please feel free to share it with your teams.Continue reading→

RiboMed Biotechnologies, Inc., a CLIA-certified diagnostic company, today announced the receipt of a $165,000 Small Business Innovative Research contract awarded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The project, entitled “Non-invasive assay for the diagnosis and treatment of endometriosis” will focus on the development of a test for early detection of endometriosis from a woman’s bodily fluids using an epigenetic biomarker panel, including gene-specific DNA methylation.Continue reading→

Breezing, a spinout company that was the result of discoveries made at Arizona State University’s Biodesign Institute, was recently named an Arizona Innovation Challenge winner by the Arizona Commerce Authority.Continue reading→